Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Maria Gontika"'
Autor:
Nikoletta Smyrni, Maria Koutsaki, Marianna Petra, Eirini Nikaina, Maria Gontika, Helen Strataki, Fotini Davora, Helen Bouza, George Damianos, Helen Skouteli, Sotiria Mastroyianni, Zoi Dalivigka, Argyris Dinopoulos, Margarita Tzaki, Antigone Papavasiliou
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: While most studies on the association of preterm birth and cerebral palsy (CP) have focused on very preterm infants, lately, attention has been paid to moderately preterm [32 to
Externí odkaz:
https://doaj.org/article/85652371508b47a194a57bc02c074621
Autor:
Maria Anagnostouli, Artemios Artemiadis, Maria Gontika, Charalampos Skarlis, Nikolaos Markoglou, Serafeim Katsavos, Konstantinos Kilindireas, Ilias Doxiadis, Leonidas Stefanis
Publikováno v:
Brain Sciences, Vol 10, Iss 6, p 374 (2020)
Background: Human Leucocyte Antigens (HLA) represent the genetic loci most strongly linked to Multiple Sclerosis (MS). Apart from HLA-DR and HLA–DQ, HLA-DP alleles have been previously studied regarding their role in MS pathogenesis, but to a much
Externí odkaz:
https://doaj.org/article/2f69c88698dd4d74b42a455a06479560
Autor:
Charalampos Skarlis, Nikolaos Markoglou, Maria Gontika, Anastasia Bougea, Serafeim Katsavos, Artemios Artemiadis, George Chrousos, Marinos Dalakas, Leonidas Stefanis, Maria Anagnostouli
Publikováno v:
Neurological Sciences. 44:693-701
Objectives Long-term immunomodulatory therapy of pediatric onset-multiple sclerosis (POMS) is based mainly on published case series and internationally agreed guidelines. Relevant studies in the Greek population are absent from the literature. The pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f7adf1b7132160dc0b2af33cd543277
https://doi.org/10.1007/s10072-022-06431-y
https://doi.org/10.1007/s10072-022-06431-y
Autor:
Maria Gontika, Charalampos Skarlis, Nikolaos Markoglou, Dimitrios Tzanetakos, Aglaia Vakrakou, Panagiotis Toulas, George Koutsis, Maria-Eleptheria Evangelopoulos, Roser Pons, Efthymios Dardiotis, George Chrousos, Marinos Dalakas, Leonidas Stefanis, Maria Anagnostouli
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 395:933-943
Pediatric-onset multiple sclerosis (MS, POMS) accounts for 3-5% of all MS cases and is characterized by a highly inflammatory profile, often warranting treatment with high-efficacy agents. Our aim is to present real-world data of a series of 18 Helle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbb0c7dee417bf0b57ada36b9089066f
https://doi.org/10.1007/s00210-022-02238-y
https://doi.org/10.1007/s00210-022-02238-y
Autor:
Marianna Petra, Eirini Nikaina, Helen Bouza, Maria Gontika, Fotini Davora, Zoi Dalivigka, Argyris Dinopoulos, Helen Strataki, Helen N. Skouteli, Margarita Tzaki, Maria Koutsaki, Antigone Papavasiliou, George Damianos, Sotiria Mastroyianni, Nikoletta Smyrni
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Frontiers in Neurology
Frontiers in Neurology
Background:While most studies on the association of preterm birth and cerebral palsy (CP) have focused on very preterm infants, lately, attention has been paid to moderately preterm [32 to Methods:In order to report on the outcomes of a cohort of mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d106daa692c64510701ae5c6bb626338
https://doi.org/10.3389/fneur.2021.628066
https://doi.org/10.3389/fneur.2021.628066
Autor:
Artemios Artemiadis, Serafeim Katsavos, Konstantinos Kilindireas, Maria Gontika, Leonidas Stefanis, Maria Anagnostouli, Ilias Doxiadis, Charalampos Skarlis, Nikolaos Markoglou
Publikováno v:
Brain Sciences
Brain Sciences, Vol 10, Iss 374, p 374 (2020)
Volume 10
Issue 6
Brain Sciences, Vol 10, Iss 374, p 374 (2020)
Volume 10
Issue 6
Background: Human Leucocyte Antigens (HLA) represent the genetic loci most strongly linked to Multiple Sclerosis (MS). Apart from HLA-DR and HLA&ndash
DQ, HLA-DP alleles have been previously studied regarding their role in MS pathogenesis, but t
DQ, HLA-DP alleles have been previously studied regarding their role in MS pathogenesis, but t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88e833a145bf9687e99dcbe9ae394e99
http://europepmc.org/articles/PMC7349544
http://europepmc.org/articles/PMC7349544
Autor:
Nikolaos Markoglou, Eleftherios Stamboulis, Serafeim Katsavos, Leonidas Stefanis, Maria Gontika, Konstantinos Kilindireas, Charalampos Skarlis, Artemios Artemiadis, Maria Anagnostouli, Panagiota Davaki
Publikováno v:
Postgraduate medicine. 131(7)
Objective: Familial Multiple Sclerosis (fMS) is reported to have distinct clinical and imaging characteristics in comparison to the sporadic disease (sMS). Nevertheless, the genetic/immunogenetic p...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea4e49768aa8e0631e60ff1e39e55f6
https://pubmed.ncbi.nlm.nih.gov/31408393
https://pubmed.ncbi.nlm.nih.gov/31408393
Autor:
Maria Gontika, Maria Anagnostouli
Publikováno v:
Human Leukocyte Antigen (HLA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fc13990d66d465c0cce38f5c50ec5b8
https://doi.org/10.5772/intechopen.81645
https://doi.org/10.5772/intechopen.81645
Autor:
Serafeim Katsavos, Maria Anagnostouli, Maria Gontika, Konstantinos Voumvourakis, Elisabeth Kapaki, Andreas Kyrozis
Publikováno v:
Neurological Research. 38:655-662
Mechanisms of angiogenesis regulate multiple sclerosis (MS) lesions' evolution, displaying both neuroprotective and harmful effects. Factors traditionally considered as purely angiogenic, like vascular endothelial growth factor (VEGF), exert complex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b71e967bbe56e4b8df8af7b8acf248b
https://doi.org/10.1080/01616412.2016.1219079
https://doi.org/10.1080/01616412.2016.1219079
Autor:
Maria Anagnostouli, Maria Gontika
Publikováno v:
Multiple Sclerosis International
Multiple Sclerosis International, Vol 2018 (2018)
Multiple Sclerosis International, Vol 2018 (2018)
Early-onset (pediatric and adolescent) multiple sclerosis (MS) is a well-established demyelinating disease that accounts for approximately 3-5% of all MS cases. Thus, identifying potential biomarkers that can reflect the pathogenic mechanisms, diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb21840c812c3fb424f0ec548e201ec
http://europepmc.org/articles/PMC6282147
http://europepmc.org/articles/PMC6282147